Cbay stock price target

CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CBAY updated stock price target summary. Cymabay Therapeutics Stock Price Forecast, CBAY stock price prediction. The best long-term & short-term Cymabay Therapeutics share price prognosis for 

Cymabay Therapeutics Stock Price Forecast, CBAY stock price prediction. The best long-term & short-term Cymabay Therapeutics share price prognosis for  Stock Price Forecast for CBAY: Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. Find the latest CymaBay Therapeutics Inc. (CBAY) stock quote, history, news and other vital NasdaqGS - NasdaqGS Real Time Price. 1y Target Est, 2.73  5 days ago Additionally, CBAY shares got another “Neutral” rating from ROTH Capital, setting a target price of $2 on the company's shares, according to the  Prev Close 1.48, 52 Wk Low 1.21. Open 1.49, 52 Wk High 13.75. Day Low 1.44, Volume 547,612.00. Day High 1.52, Avg 10D Vol 1.5M  Get today's Cymabay Therapeu stock price and latest CBAY news as well as Cymabay Therapeu real-time stock quotes, technical analysis, full financials and   In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, Cymabay Therapeutics to Outperform From Perform, Sets $4 Price Target.

6 Mar 2020 (NASDAQ:CBAY) is now rated as Neutral. Their price target on the stock stands at $2. Even though the stock has been trading at $1.84/share, 

CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CBAY updated stock price target summary. Cymabay Therapeutics Stock Price Forecast, CBAY stock price prediction. The best long-term & short-term Cymabay Therapeutics share price prognosis for  Stock Price Forecast for CBAY: Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate.

5 days ago Additionally, CBAY shares got another “Neutral” rating from ROTH Capital, setting a target price of $2 on the company's shares, according to the 

Cymabay Therapeutics Stock Price Forecast, CBAY stock price prediction. The best long-term & short-term Cymabay Therapeutics share price prognosis for  Stock Price Forecast for CBAY: Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. Find the latest CymaBay Therapeutics Inc. (CBAY) stock quote, history, news and other vital NasdaqGS - NasdaqGS Real Time Price. 1y Target Est, 2.73 

©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed 

The 6 analysts offering 12-month price forecasts for Cymabay Therapeutics Inc The current consensus among 6 polled investment analysts is to Buy stock in  Their average twelve-month price target is $5.81, suggesting that the stock has a possible upside of 287.33%. The high price target for CBAY is $18.00 and the  12 brokers have issued 1 year target prices for CymaBay Therapeutics' stock. Their forecasts range from $1.50 to $18.00. On average, they anticipate CymaBay  Based on 6 analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $2.78 with a high forecast of  CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CBAY updated stock price target summary. Cymabay Therapeutics Stock Price Forecast, CBAY stock price prediction. The best long-term & short-term Cymabay Therapeutics share price prognosis for 

Based on 6 analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $2.78 with a high forecast of 

31 Jan 2020 Those same analysts give the stock an average rating of Buy. That average rating puts CymaBay Therapeutics Inc higher than 18 of stocks, based  4 Mar 2020 Analysts' Opinion on CymaBay Therapeutics, Inc. (NASDAQ:CBAY) gave “ Neutral” rating to CBAY stocks, setting the target price at $2 in the  13 Mar 2020 CBAY earnings call for the period ending December 31, 2019. could differ materially from those forecast due to the impact of many factors. severance costs, $0.9 million of non-cash stock-based compensation expense  16 Sep 2019 Shares of the biotech CymaBay Therapeutics (CBAY) appear to be in the The software is projecting a possible downside price target of $0  12 Jun 2019 Raymond James analyst Steven Seedhouse says the stock is now a Strong Buy. upgraded CymaBay (ticker: CBAY) from Outperform to Strong Buy, “We maintain our $19 price target and upgrade to Strong Buy given the  1 Oct 2019 The only reason insiders buy a company's stock is that they believe The average target price is $18.20, about 30% higher than where it is  6 Mar 2020 (NASDAQ:CBAY) is now rated as Neutral. Their price target on the stock stands at $2. Even though the stock has been trading at $1.84/share, 

Prev Close 1.48, 52 Wk Low 1.21. Open 1.49, 52 Wk High 13.75. Day Low 1.44, Volume 547,612.00. Day High 1.52, Avg 10D Vol 1.5M  Get today's Cymabay Therapeu stock price and latest CBAY news as well as Cymabay Therapeu real-time stock quotes, technical analysis, full financials and   In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, Cymabay Therapeutics to Outperform From Perform, Sets $4 Price Target. ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed  CBAY investment & stock information. Get the latest CymaBay Therapeutics Inc . CBAY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Stable Share Price: CBAY's share price has been volatile over the past 3 Did CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Insiders Buy Up More Shares? Earnings vs Market: CBAY is forecast to remain unprofitable over the next 3 years . 31 Jan 2020 Those same analysts give the stock an average rating of Buy. That average rating puts CymaBay Therapeutics Inc higher than 18 of stocks, based